240 related articles for article (PubMed ID: 31401072)
1. Translating plasma eicosapentaenoic acid concentrations into erythrocyte percentages of eicosapentaenoic acid plus docosahexaenoic acid during treatment with icosapent ethyl.
Harris WS; Jackson KH
J Clin Lipidol; 2019; 13(5):771-777. PubMed ID: 31401072
[TBL] [Abstract][Full Text] [Related]
2. Lipid effects of switching from prescription EPA+DHA (omega-3-acid ethyl esters) to prescription EPA only (icosapent ethyl) in dyslipidemic patients.
Crandell JR; Tartaglia C; Tartaglia J
Postgrad Med; 2016 Nov; 128(8):859-864. PubMed ID: 27684412
[TBL] [Abstract][Full Text] [Related]
3. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid.
Allaire J; Harris WS; Vors C; Charest A; Marin J; Jackson KH; Tchernof A; Couture P; Lamarche B
Prostaglandins Leukot Essent Fatty Acids; 2017 May; 120():8-14. PubMed ID: 28515020
[TBL] [Abstract][Full Text] [Related]
4. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.
Chapman MJ; Zamorano JL; Parhofer KG
Pharmacol Ther; 2022 Sep; 237():108172. PubMed ID: 35304222
[TBL] [Abstract][Full Text] [Related]
5. Effects of switching from omega-3-acid ethyl esters to icosapent ethyl in a statin-treated patient with elevated triglycerides.
Kedia AW; Lynch E
Postgrad Med; 2015; 127(8):869-73. PubMed ID: 26453247
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional study of the combined associations of dietary and supplemental eicosapentaenoic acid + docosahexaenoic acid on Omega-3 Index.
McDonnell SL; French CB; Baggerly CA; Harris WS
Nutr Res; 2019 Nov; 71():43-55. PubMed ID: 31757628
[TBL] [Abstract][Full Text] [Related]
7. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial.
Flock MR; Skulas-Ray AC; Harris WS; Etherton TD; Fleming JA; Kris-Etherton PM
J Am Heart Assoc; 2013 Nov; 2(6):e000513. PubMed ID: 24252845
[TBL] [Abstract][Full Text] [Related]
8. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on plasma and red blood cell fatty acids in patients with very high triglyceride levels (results from the MARINE study).
Braeckman RA; Manku MS; Bays HE; Stirtan WG; Soni PN
Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):195-201. PubMed ID: 23992935
[TBL] [Abstract][Full Text] [Related]
9. Predicting the effects of supplemental EPA and DHA on the omega-3 index.
Walker RE; Jackson KH; Tintle NL; Shearer GC; Bernasconi A; Masson S; Latini R; Heydari B; Kwong RY; Flock M; Kris-Etherton PM; Hedengran A; Carney RM; Skulas-Ray A; Gidding SS; Dewell A; Gardner CD; Grenon SM; Sarter B; Newman JW; Pedersen TL; Larson MK; Harris WS
Am J Clin Nutr; 2019 Oct; 110(4):1034-1040. PubMed ID: 31396625
[TBL] [Abstract][Full Text] [Related]
10. The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention.
Trivedi K; Le V; Nelson JR
Postgrad Med; 2021 Jan; 133(1):28-41. PubMed ID: 32762268
[TBL] [Abstract][Full Text] [Related]
11. Survey of the erythrocyte EPA+DHA levels in the heart attack/stroke belt.
Harris WS; Jackson KH; Brenna JT; Rodriguez JC; Tintle NL; Cornish L
Prostaglandins Leukot Essent Fatty Acids; 2019 Sep; 148():30-34. PubMed ID: 31492431
[TBL] [Abstract][Full Text] [Related]
12. Changes in Erythrocyte Omega-3 Fatty Acids in German Employees upon Dietary Advice by Corporate Health.
Rein D; Claus M; Frosch W; März W; Lorkowski S; Webendoerfer S; Schreiner T
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113826
[TBL] [Abstract][Full Text] [Related]
13. Association of reported fish intake and supplementation status with the omega-3 index.
Jackson KH; Polreis JM; Tintle NL; Kris-Etherton PM; Harris WS
Prostaglandins Leukot Essent Fatty Acids; 2019 Mar; 142():4-10. PubMed ID: 30773210
[TBL] [Abstract][Full Text] [Related]
14. Translating plasma and whole blood fatty acid compositional data into the sum of eicosapentaenoic and docosahexaenoic acid in erythrocytes.
Stark KD; Aristizabal Henao JJ; Metherel AH; Pilote L
Prostaglandins Leukot Essent Fatty Acids; 2016 Jan; 104():1-10. PubMed ID: 26802936
[TBL] [Abstract][Full Text] [Related]
15. Icosapent ethyl: Eicosapentaenoic acid concentration and triglyceride-lowering effects across clinical studies.
Bays HE; Ballantyne CM; Doyle RT; Juliano RA; Philip S
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():57-64. PubMed ID: 27418543
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: implications for clinical utility.
Harris WS; Varvel SA; Pottala JV; Warnick GR; McConnell JP
J Clin Lipidol; 2013; 7(5):433-40. PubMed ID: 24079284
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance.
Maki KC; Johns C; Harris WS; Puder M; Freedman SD; Thorsteinsson T; Daak A; Rabinowicz AL; Sancilio FD
Clin Ther; 2017 Mar; 39(3):652-658. PubMed ID: 28189365
[TBL] [Abstract][Full Text] [Related]
18. Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements.
Miller M; Tokgozoglu L; Parhofer KG; Handelsman Y; Leiter LA; Landmesser U; Brinton EA; Catapano AL
Expert Rev Cardiovasc Ther; 2022 Aug; 20(8):609-625. PubMed ID: 35876118
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 index is directly associated with a healthy red blood cell distribution width.
McBurney MI; Tintle NL; Harris WS
Prostaglandins Leukot Essent Fatty Acids; 2022 Jan; 176():102376. PubMed ID: 34839221
[TBL] [Abstract][Full Text] [Related]
20. Icosapent ethyl: drug profile and evidence of reduced residual cardiovascular risk in patients with statin-managed LDL-C cholesterol.
Bazarbashi N; Miller M
Expert Rev Cardiovasc Ther; 2020 Apr; 18(4):175-180. PubMed ID: 32228246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
